Form 8-K - Current report:
SEC Accession No. 0001193125-20-240512
Filing Date
2020-09-08
Accepted
2020-09-08 07:13:34
Documents
12
Period of Report
2020-09-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d29102d8k.htm   iXBRL 8-K 22958
  Complete submission text file 0001193125-20-240512.txt   148276

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20200908.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20200908_lab.xml EX-101.LAB 18907
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20200908_pre.xml EX-101.PRE 11878
5 EXTRACTED XBRL INSTANCE DOCUMENT d29102d8k_htm.xml XML 3484
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 201162941
SIC: 2834 Pharmaceutical Preparations